.png)
Patented Stem Cell Solutions for Complex Auto-Immune Disorders & Unmet Needs
Targeting inflammatory diseases with stem cell science
NSB is an innovative biotechnology company advancing novel technologies to treat immune-mediated inflammatory diseases. Our research specialises in mesenchymal stem cells (MSCs) -adult stem cells with unique properties to reduce inflammation, repair damaged tissue, and support the body’s natural immune response.
What are Mesenchymal Stem Cells (MSC)?
How does Stem Cell technology work?
MSC are adult stem cells traditionally harvested from bone marrow. MSC can also be isolated from other tissues.
Stem cells are often called the “body's building blocks”, as they can potentially develop into any tissue or organ. Mesenchymal stem cells interact with the immune system, adjusting immune responses and reducing inflammation in target tissue, contributing to disease control and tissue repair.
StemSmart™: Advancing Stem Cell Therapy
A patented, high-quality platform for immune disease treatment
StemSmart™ is a globally patented technology designed to enhance the safety and efficacy of mesenchymal stem cell (MSC) therapies. Manufactured under GMP standards with a TGA product manufacturing licence, StemSmart™ products are consistently produced using a proprietary process that primes cells for stronger responses to inflammation. Early Phase 2 trial results in refractory Crohn’s disease indicate StemSmart™ MSC is potent, efficacious, and safe.